Navigation Links
Final countdown: Atlantis to carry next-generation vaccine candidate on last space voyage
Date:7/6/2011

s shown promise in phase 1 human clinical trials. The ability of spaceflight to enhance the efficacy of this recombinant attenuated Salmonella vaccine, or RASV, will be the focus of the Atlantis mission.

Current experiments aboard STS-135 will build on decades of earlier research by Nickerson and Curtiss, in attempts to improve the effectiveness of RASVs. These vaccines exploit Salmonella's renowned infectious capacity in order to produce a strong, system-wide immune response. In addition to the defensive response to Salmonella, the vaccine recipient also marshals an immune response to secondary disease antigens studded on the pathogen's surface membranein this case, antigens to pneumococcus, the causative agent of pneumonia.

"Many breakthroughs in life sciences research and translational advancements to the healthcare setting, have been achieved through studying the response of biological systems to extreme environments," Nickerson says. The extreme environment in the present study is the reduced gravity present during spaceflight, which alters a fundamental physical property encountered by living cells, known as fluid shear.

Fluid shear refers to the physical forces exerted on cells by the extracellular liquids surrounding them. Previous experiments by Nickerson aboard the space shuttles Endeavour and Atlantis showed that changes in fluid shear due to microgravity induced important cellular responses in pathogens, including unique alterations in gene expression and virulence.

Nickerson notes that the responses of pathogenic cells to microgravity may be closely correlated with their behavior during infection here on earth, where the effects of low fluid shear environments present in the body are believed to contribute to virulence. Such pathogen responses, however, may often evade detection in conventional in vitro experiments on earth, where gravity may be masking this effect. In the current study, th
'/>"/>

Contact: Joseph Caspermeyer
Joseph.Caspermeyer@asu.edu
Arizona State University
Source:Eurekalert  

Page: 1 2 3 4

Related biology technology :

1. SCOLR Pharma, Inc. Announces Final Closing of Private Placement
2. Keryx Biopharmaceuticals Announces Positive Final Data from Zerenex™ Short-Term Phase 3 Study
3. TEI Biosciences Chairman, President and CEO Yiannis Monovoukas Named Ernst & Young Entrepreneur Of The Year® 2011 New England Award Semifinalist
4. Mtech Announces Semifinalists for University of Maryland $75K Business Plan Competition
5. Helix BioPharma Completes Definitive GLP Toxicology Studies With L-DOS47 and is Making Final Preparations for its Planned Phase I/II Clinical Study IND/CTA Submissions
6. Dyadic International Announces Final Resolution and Dismissal of Stockholder Class Action Lawsuit
7. Study Finds BYETTA(R) Use Was Not Associated With Increased Rate of Acute Pancreatitis Compared to Other Antidiabetic Drugs: Final Results Presented at ADA 2010
8. Alexandria Real Estate Equities, Inc. Receives Final Approval From City of Cambridge to Develop Its East Cambridge State-of-the-Art Life Science Community
9. ChemoCentryx President and CEO, Thomas J. Schall, Ph.D., Named Ernst & Young Entrepreneur Of The Year 2010 Award Finalist in Northern California
10. ViroPharma Announces Availability of Cinryze(TM) (C1 Esterase Inhibitor [Human]) Final Open-Label Data
11. Profil Institutes Dr. Marcus Hompesch Named Finalist in Ernst & Young Entrepreneur Of The Year(R) 2010 Award for Second Year in a Row
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Final countdown: Atlantis to carry next-generation vaccine candidate on last space voyage
(Date:7/11/2014)... 2014 Research and Markets  has announced ... - Global Industry Analysis, Size, Share, Growth, Trends and ... http://photos.prnewswire.com/prnh/20130307/600769 Transfection ... DNA or RNA) into cells. This technology helps the ... and protein metabolism by affecting the nuclear genes. The ...
(Date:7/11/2014)... 11, 2014  Researchers have pioneered a revolutionary ... new technology, called Virtual Finger, allows scientists to ... neurons and synapses using the flat surface of ... 3D imaging studies orders of magnitude more efficient, ... level across many areas of experimental biology. The ...
(Date:7/10/2014)... (PRWEB) July 10, 2014 Deep ... Century Medicine Forum on ‘Commercialising Longevity Research’ and ... entrepreneurs to the London Bioscience Innovation Center for ... Foundation and Aging Analytics Ltd. The meeting highlighted ... in translational research for age-related disease, as well ...
(Date:7/10/2014)... Robert Harman, DVM, Founder and CEO of Vet-Stem, ... announce the relaunch of his highly informative blog, now named ... “ What are Stem Cells ?” Dr. Harman’s purpose ... in the basics of stem cell therapy so that pet ... of treatment when considering regenerative medicine. , A veterinarian by ...
Breaking Biology Technology:International Transfection Technology Market - Industry Analysis, Size, Share, Growth, Trends and Forecast to 2019 2Virtual Finger Enables Scientists To Navigate And Analyze 3D Images Of Complex Biological Structures 2Virtual Finger Enables Scientists To Navigate And Analyze 3D Images Of Complex Biological Structures 3DKV Sponsors Forum on Commercialising Longevity Research; Brings Together Scientists, Investors, Entrepreneurs and Celebrities 2DKV Sponsors Forum on Commercialising Longevity Research; Brings Together Scientists, Investors, Entrepreneurs and Celebrities 3DKV Sponsors Forum on Commercialising Longevity Research; Brings Together Scientists, Investors, Entrepreneurs and Celebrities 4DKV Sponsors Forum on Commercialising Longevity Research; Brings Together Scientists, Investors, Entrepreneurs and Celebrities 5DKV Sponsors Forum on Commercialising Longevity Research; Brings Together Scientists, Investors, Entrepreneurs and Celebrities 6Robert Harman, DVM Talks About What Stem Cells are in His Latest Blog Series for Vet-Stem, Inc. 2Robert Harman, DVM Talks About What Stem Cells are in His Latest Blog Series for Vet-Stem, Inc. 3
... Amarin Corporation plc,(NASDAQ: AMRND ) today announced that, ... 1 for 10 reverse split of each of its ... close of business,yesterday, January 17, 2008., Thomas Lynch, ... pleased to report that over 95% of the votes ...
... ... now means that all the population is susceptible to ... the disease, - Increased concerns over "second wave" of vCJD in individuals with much ... longer incubation times - P-Capt(R) prion reduction filter still the only proven method of protecting ...
... Calif. University of California, Irvine researchers have identified ... cerebral cortex, a finding that could lead to stem ... as stroke and Alzheimers. , Dr. Edwin Monuki, doctoral ... of Pathology & Laboratory Medicine and Developmental & Cell ...
Cached Biology Technology:Amarin Provides Business Update and Announces Implementation of Reverse Stock Split 2Amarin Provides Business Update and Announces Implementation of Reverse Stock Split 3Amarin Provides Business Update and Announces Implementation of Reverse Stock Split 4Amarin Provides Business Update and Announces Implementation of Reverse Stock Split 5Amarin Provides Business Update and Announces Implementation of Reverse Stock Split 6Amarin Provides Business Update and Announces Implementation of Reverse Stock Split 7Amarin Provides Business Update and Announces Implementation of Reverse Stock Split 8Amarin Provides Business Update and Announces Implementation of Reverse Stock Split 9ProMetic and MacoPharma announce successful completion of P-Capt(R) prion reduction filter clinical studies 2ProMetic and MacoPharma announce successful completion of P-Capt(R) prion reduction filter clinical studies 3ProMetic and MacoPharma announce successful completion of P-Capt(R) prion reduction filter clinical studies 4ProMetic and MacoPharma announce successful completion of P-Capt(R) prion reduction filter clinical studies 5Discovery of 'creator' gene for cerebral cortex points to potential stem cell treatments 2
(Date:7/11/2014)... Shenzhen, China Researchers from Salk Institute for Biological ... time evaluated the safety and reliability of the ... a new method, TALEN-HDAdV, which could significantly increased ... (hiPSC). This study published online in Cell ... for stem cell-based gene therapy. , The combination ...
(Date:7/11/2014)... Researchers have pioneered a revolutionary new way ... called Virtual Finger, allows scientists to move through ... synapses using the flat surface of their computer ... studies orders of magnitude more efficient, saving time, ... many areas of experimental biology. The software and ...
(Date:7/11/2014)... is evidence that under the normal circumstances, ... development, maintain neuronal environment, and exhibit therapeutic ... neurodegenerative disease. Previous studies have found that ... after chemical induction have reduced viability, which ... Prof. Xiaodong Yuan, Kailuan General Hospital, Hebei ...
Breaking Biology News(10 mins):A new genome editing method brings the possibility of gene therapies closer to reality 2Virtual finger enables scientists to navigate and analyze complex 3D images 2
... 4, 2013   MedNet Solutions , a global life ... is pleased to announce its sponsorship of, participation in, ... 10-13 in Chicago .  MedNet is ... conference...the largest and most prestigious clinical data management event ...
... anti-cancer drugs and other medicines inside soil microbes and other ... given humanity more than 50 percent of today,s prescription drugs. ... cover story in Chemical & Engineering News , the ... Jarvis, C&EN senior editor, points out that natural products are ...
... useful medical information beyond what current newborn screening already ... being funded by the Eunice Kennedy Shriver National Institute ... National Human Genome Research Institute (NHGRI), both parts of ... to four grantees have been made in fiscal year ...
Cached Biology News:MedNet Solutions To Sponsor The SCDM Annual Conference For The Eighth Straight Year 2NIH program explores the use of genomic sequencing in newborn healthcare 2NIH program explores the use of genomic sequencing in newborn healthcare 3NIH program explores the use of genomic sequencing in newborn healthcare 4